Q3 2024 Clover Health Investments Corp Earnings Call Transcript
Key Points
- Clover Health Investments Corp (CLOV) reported another quarter of meaningful adjusted EBITDA profitability and positive operating cash flow, leading to an improved full-year adjusted EBITDA guidance.
- The company achieved industry-leading loss ratios driven by strong performance in PMPM revenue and medical expense management.
- Clover Health received upgraded star ratings for its plans, including a four-star rating for its flagship PPO, impacting payment year 2026.
- The technology-driven Clover Assistant has been instrumental in managing total cost of care and quality, contributing to strong clinical and financial performance.
- Clover Health has significantly increased its adjusted EBITDA profitability to over $62 million year-to-date on a membership base of 81,000 lives, positioning the company well for future growth.
- Despite improvements, Clover Health Investments Corp (CLOV) still reported a GAAP net loss of $9 million for the third quarter.
- The company anticipates unregulated liquidity levels to be impacted by a final payment of $39 million related to its 2023 ACO Reach participation.
- Clover Health's insurance Benefits Expense Ratio (BER) and Medical Cost Ratio (MCR) showed only slight improvements compared to the previous year.
- The company is facing market volatility, which requires strategic investments to maintain growth and quality initiatives.
- Clover Health's counterpart health SaaS and tech-enabled services solution is still in early stages, with insignificant profitability impact expected this year.
Ladies and gentlemen, good afternoon and welcome to the Clover Health third quarter, 2024 earnings conference call at this time. All participants are in a listen-only mode, a question and answer session will follow the prepared remarks at that time. If you wish to ask a question, please press *1 on your telephone keypad. As a reminder, today's call is being recorded.
I would now like to turn the call over to Ryan Schmidt Investor Relations for Clover Health. Please go ahead.
Good afternoon, everyone. joining me on our call today to discuss the company's third quarter 2024 results are Andrew Toy, Clover Health's Chief Executive Officer; and Peter Kuipers, the company's Chief Financial Officer.
You can find today's press release in the company's supplemental slides as well as the company's most recent investor deck in the investor events and presentations section of our website at investors.cloverhealth.com. This webcast is being recorded and a replay will be available in the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
